ASCO Daily News

Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok

Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year CheckMate-067 surv

Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities

Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of no

How Do We Translate ASCO26 Research Into Practice in Latin America?

In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can

GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?

Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microe

From Abstract to Action: Translating ASCO26 Research Into Global Practice

How do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical realities, oppo

Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough

Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-

Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1

Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that were present

GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that were presented at the 2026 ASC

Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers

Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were

GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More

Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annu

Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More

Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid malignancies,

Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More

Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lu

Day 5: Top Takeaways From ASCO26

Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies fo

Day 4: Top Takeaways From ASCO26

Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lun

Day 3: Top Takeaways From ASCO26

Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanc

Day 2: Top Takeaways From ASCO26

Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-neg

Day 1: Top Takeaways From ASCO26

In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urot

ASCO26 Preview: Novel Therapies and Innovations in Cancer Care

Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting. LINK TO FU

The Future of AI in Oncology: A Conversation With Google's AI Innovators

Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate Medical Intellige

'No Margin for Error': What to Know Before Implementing AI in Clinical Practice

Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice and how overreliance on AI cou